Market Tracker

12/19 6:05pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

56.64
Data as of Dec 19
 -1.04 / -1.80%
Today’s Change
35.33
Today|||52-Week Range
93.33
-6.02%
Year-to-Date

Today’s Trading

Previous close57.68
Today’s open57.54
Day’s range56.42 - 58.71
Volume1,138,826
Average volume (3 months)781,991
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+0.67%
Earnings growth (this year)-43.70%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+1.73+3.15%
NBIXNeurocrine Bioscienc...+0.59+2.47%
MDCOMedicines Co+0.27+1.00%
IRWDIronwood Pharmaceuti...-0.27-1.79%
Data as of 3:59pm ET, 12/19/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$0.00
Annual profit (last year)-$84.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial Officer, Secretary &
Executive VP
Erle T. Mast
Corporate headquarters
Boulder, Colorado

Forecasts